Background
Of the 2.1 million HIV-infected adolescents, 83% of these reside in sub-Saharan Africa [
1]. In 2013, for the first time age-disaggregated estimated numbers of adolescents living with HIV (ALHIV) were presented in a global report that estimated 250,000 new HIV infections and 120,000 AIDS-related deaths among adolescents in that year [
1]. Further to this, adolescents were the only age group in which AIDS-related deaths had not decreased in the period from 2005 to 2013 contrasting sharply with the reported cumulative 38% decline in all the other age groups [
2]. An additional observation was the very low scale up and treatment of ALHIV.
The global
All In campaign to end adolescent AIDS was officially launched in Kenya in February 2015 [
2]. Kenya then released a
Fast Track Plan to End Adolescent AIDS in September of the same year [
3].
Implicit in the planned response is the assumption that adolescents will be able to take charge of their health care and all interventions would be multisectoral. Additionally, there is a tendency to lump all adolescents together failing to take into consideration that adolescence is a period of rapid growth and that there is significant lapse in time between sexual maturation taking place in adolescence (10–14 years) and/or emotional and cognitive maturation that takes place in late adolescence (17–24 years). This period of human development has well-described complex challenges that the HIV-infected adolescents have to get attuned to in addition to the problems related to their illness. Given that mental health issues are an emerging public health priority with suicide ranked as third highest cause of death among adolescents globally [
4], ALHIV have higher prevalence rates of depression, anxiety, conduct, and functional disorders compared to HIV-unaffected adolescents [
5‐
7]. HIV-related psychosocial problems include stigma and discrimination, relationship challenges such as HIV status disclosure, difficulties with their medication, loss of biological parents in cases of orphans, denial and ambivalence towards HIV, and school performance [
8‐
10]. These have a major impact in the quality of life and if not adequately addressed can lead to poor outcomes [
11]. These psychosocial adversities impact negatively on adherence to combined antiretroviral (cARV) medication [
12,
13] and predispose adolescent greater depression risk. Risk factors such as being female, fewer years of schooling, death within the household, poor school performance, being in a relationship with the opposite sex, non-disclosure of HIV status, severe immunosuppression, and bullying in school for taking medication have been shown to be associated with depression [
14].
Adolescence and especially mid-adolescence is characterized by increased exploration of one’s environments and feelings of invincibility. In the process, a significant number of adolescents engage in risky behaviors including high-risk sexual encounters that expose them to sexually transmitted infections and unplanned pregnancies [Ndugwa et al., Patel et al.]. Experimentation with psychoactive agents such as alcohol and others may lead to addiction and fuel poor sexual-decision making. ALHIV have the additional stress of putting their partner at risk, challenges with disclosure of HIV status, and adverse drug reactions from the psychoactive agents or with use of hormonal contraceptive [
14,
15].
The purpose of this study was to highlight key psychosocial characteristics of HIV-infected adolescents and explore if these characteristics predict depression. The WHO AA-HA 2017 recommends competencies and intervention implementation targeting different developmental age groups and using HEADSS framework as a guidance tool. We feel our work aligns closely to the WHO adolescent care framework [
4], as understanding and describing these psychosocial characteristics of HIV-infected adolescents will aid in design and implementation of treatment and follow-up programs that are tailor-made for their needs, thereby reversing the negative trends in this age group (notably these are reducing risky sexual behavior and consequently reducing new HIV infections, addressing issues pertaining disclosure, adherence to medication, and stigma/discrimination).
Discussion
This study is among the few in Kenya to comprehensively assess at the health facility various psychosocial issues that are faced by ALHIV. Of importance is that these issues have not become part of routine assessment and management during regular clinic visits and these psychosocial correlates in the literature have been strongly associated with depression. The HEADSS tool framework was adopted into the adolescent tool kit called Adolescent Package of Care (APOC) by the Kenya Ministry of health to support care of adolescents; however, the specific questionnaire has not been adapted into the Kenyan context yet [
17]. The standard HEADSS tool was shortened and adapted to the Kenyan context and a standard depression screening tool added. The tool is included as supplementary study material. This is the first study to provide empirical evidence on the performance of this HEADSS framework in assessing ALHIV since this framework was adopted in APOC guidelines. As noted in our introduction, WHO AA-HA (2017) stipulates the use of HEADSS tool for not only needs assessment but as a framework for intervention development looking at different developmental competencies and domains in which adolescent development and health care needs have to be conceptualized [
4].
In line with this, our work despite its shortcoming and narrow scope (being restricted to health facility) has high operational validity as we have directly explored with adolescents about their ongoing treatment and mental health needs. We have bifurcated analyses based on differential developmental competencies [
18]. National adolescent priorities have been laid out in a number of complementary guidelines. The Kenyan national adolescent reproductive and sexual health policy [
18], Vision 2030 [
19], and UN SDGs such as goals focus on adolescent health. The Kenyan national policy focuses on adolescents’ needs that have been specifically targeted such as reducing early sexual debut, knowledge about HIV transmission, and prevention in adolescent girls and boys and in adolescents of ages 10–14 and 15–24 years.
We evaluated 270 adolescents and a wide majority (99.6%) as would be expected were still in formal education at different tiers. A study done by Souza et al. (2010) had a higher dropout rate, with 89.8% in school in the same population in Brazil [
10]. Despite high numbers of those in formal education, the challenges came in the form of financial constraints that came in the way of parental capacity to pay for school fees in time. In our sample, 44.1% alluded to missing school due to unpaid school fees which prompted the school to discontinue these candidates. Additionally, there were also concerns about dropping school performance in 18.1% of our sample with 33.7% having repeated a grade and 18.5% having had difficult bullying experiences at school. In a study by Shavisa et al. [
20], school dropout rates in the general population were 1.34 and 1.06% among boys and girls, respectively. The shame associated with poor performance and failure in tests may have exacerbated experiences of bullying. Bullying of vulnerable child who live in adversities also needs greater attention. A systematic review done found that problems with school functioning need early detection and intervention and prolonged problems may lead to long-term adjustment and psychological disorders [
10].
Our study found older adolescents (age 15–19 years) with a twofold increased risk of depression. Adolescence is a period of significant cognitive and socio-emotional development [
21]. Mental illness may manifest in a different way as these capacities develop. Given the complex pathogenesis of HIV illness, mental health problems, poor neurocognitive functioning, and psychosocial adversities in such vulnerable adolescents are subsets of an inter-related problem. Additionally, due to the HIV infection, these developing capacities are also compromised in ways that are also yet to be fully understood in both neurocognitive and psychosocial senses. Our cross-sectional study design does not equip us sufficiently to extend this argument based on these results but the literature is replete with similar conclusions [
12]. In this study, we used PHQ-9 to screen for depression symptoms and as such we did not find depression prevalence to be high, although we did find that 12 (4.4%) participants reported suicidal ideation whom we referred for suicide watch and priority mental health care. The use of a standardized check list to screen for symptoms of depression was therefore a huge benefit for this set of study participants.
The other independent predictors for depression were repeating a class and poverty measured by the surrogate markers that included missing meals and being sent away from school due to inability to source school fees. There is emerging evidence from the National HIV program that school environment frequently destabilizes the adolescent leading to poor drug adherence [
22]. In this study, we show two school-related factors that were associated, repeated changing of schools and being sent away due to lack of school fees, both factors connected to the material conditions of the families.
One in two of the adolescents in the study were not adherent to their medication. The measure of adherence in this study was a crude one in that it relied on self-reporting. A study by Vreeman et al. [
23] comparing the use of Medication Events Monitoring System (MEMS) versus self-reported adherence demonstrated over-reporting in the latter group. Further to this, non-adherence was one of the independent predictors of depression symptoms. In this cross-sectional study, we cannot reliably say what came first. There may be merit in offering psychotherapy immediately to ALHIV who have symptoms of depression as a preventative measure.
One in three adolescents live in an environment where they are exposed to drugs and other substances of abuse. One in ten of the adolescents interviewed reported substance abuse with alcohol being the most commonly used. The use of drugs increased the presence of depression symptoms by 70%. These findings are very critical as related studies have found a strong association between mental health problems, risky sexual behaviors, and substance abuse [
24] in both HIV- and non-HIV-infected adolescents. There should then be a deliberate effort to inform and counsel adolescents on the harms of drug and substance use. There is a need for further work on the tool to clarify whether the ALHIV really understand when we use the term ‘drugs’ in this context given the fact that they are on medication all the time.
The study found that involuntary missing of meals due to unavailability of food in the household was also associated with twofold increased risk of depression. People living with HIV are instructed to ensure that they do not miss meals as they take their cARV and we commonly find that people attribute non-adherence to paucity of food and to a fallacy that given the food insecurity, taking drugs without food would be harmful for the body. All these experiences probably increase the sense of vulnerability and stigma for the adolescent who lives among so many social, financial, and emotional adversities. This study did not collect formative data that would better explain the impact of these factors on the adolescents and we do feel this is an important area to invest in. A study carried out in Malawi by Kim et al. [
14] found bullying because of being on medication, severe immunosuppression, and having a boyfriend/girlfriend was associated with depression. This study did not find any significant associations between depression symptoms and bullying and we did not collect data on the state of immunosuppression.
Another important finding was that just under two-thirds of the adolescents have been fully disclosed of their HIV status. Surprisingly depression was not associated with disclosure in our univariate analysis (OR 1.34;
P = 0.3). There is a need for further studies to validate this observation. Health care workers may be deferring disclosure to ALHIV to those who are overtly depressed to manage their mental health first before a proper disclosure is planned. Disclosure we know is also a process which needs pre-disclosure, disclose, and post-disclosure stage planning [
25]. One of the key steps for ALHIV is to gradually take on responsibility for one’s own care. Full disclosure would then give meaning to the health education and actions that the adolescent is instructed to follow. The important questions before us are as follows: does disclosure trigger or worsen depression, and further to this does it have an impact on drug adherence if the disclosure experiences have been negative or ambivalent?
Although not associated with depression, just over one in 10 adolescents had made a sexual debut. Among those adolescents interviewed who were 12 years and older, 13.6% reported being sexually active or having had a sexual encounter. These experiences were more common among ages 15–19 years. According to Kenya Demographic and Health Survey 2014, 37.3% of adolescents aged 15–19 years reported ever having sex [
26] a higher prevalence compared to our study participants suggesting that HIV-infected adolescents may be postponing sexual debut or have delays in development due to recurring or chronic illness. There is considerable variability in proportion of HIV-infected adolescents who have achieved sexual debut with a Ugandan study reporting a third [
15], while in South Africa, Toska et al. [
27] found a prevalence of 14.9% in their study sample. These differences may reflect variability in the age composition of the study population and also the prevalent norms on adolescent sexuality in different cultural settings.
In our study, the majority of the adolescents who had achieved sexual debut reported inconsistent condom use similar to a Ugandan study that showed 76.5% of ALHIV inconsistently used condoms [
9], a finding that underscores the need to bolster sexual and reproductive health education in this group. Inconsistent use of condoms poses important challenges including reinfection of a HIV-infected partner with risk of transmitting resistant strains, transmission of HIV to their uninfected partners, and acquisition and transmission of sexually transmitted diseases. In our study, 27% of adolescents did not think that condoms reduced HIV transmission, while another 26.3% did not know if condoms reduced transmission of HIV. This is also an alarming response from our participants whose knowledge about sexual protection appeared to be deficient warranting a better framing of SRH education policy in schools and communities. The majority of adolescents in our study obtained condoms from health facilities; however, health care workers did not feature as a key source of information about HIV and other reproductive health issues. This maybe an indication of limited contact between adolescents and health workers or missed opportunities within the health facilities or lack of a structured method for collecting information like this study did using the HEADSS framework.
We think that the HEADSS framework offered us an opportunity to identify the adolescents who needed more immediate or focused services and further management. An alarming finding in this context was that one in four sexual debuts might have been due to a forced encounter or due to abuse. This clearly conveys the evidence of adverse childhood experiences that need to be understood better and adolescents who have had an adverse experience of coerced sex or abuse need emergency services, counseling, and socio-legal protection from further abuse. The adolescent clinic can be the point of referral for such young persons to child protection services who would need to be more responsive to needs of those young people who present with chronic illnesses or infections like HIV. Another notable finding is that about nine out of ten ALHIV are not sexually active and this offers a great opportunity to introduce psychoeducation and preventive health services that such adolescents could benefit from. Building their parents/guardians’ or health worker skills on how to support their adolescent to adopt safe approach to their sexuality would be the next step.
This study has several strengths that include a validated adolescent evaluation framework such as HEADSS. The study was conducted in a well-established clinic that had followed many of the adolescents since childhood in the context of their HIV care. All the adolescents were on antiretroviral drugs. The study was conducted during the school holidays so that adolescents in boarding school had an equal opportunity to participate similar to those in day schools. All the adolescents approached for the study accepted to participate and so did their guardians indicating that there is minimal non-participation bias and eagerness to share experiences in this group. In order to ensure informed consent and respect for the relationship between the adolescent and the parent/guardian, the researchers first approached the guardian for permission before assent by the adolescent. This overwhelming participation probably reflects that young people are very responsive to mental health care services and do have a strong desire to engage with providers on addressing their needs.
In published literature, the PHQ-9 tool has been validated among non-HIV-infected adolescents in the USA [
16]. In Africa, this tool has been used among HIV-infected adults in Western Kenya [
20] and among adolescents living with HIV in Tanzania. In the latter study, severity of depression was computed as score of 10 or greater based on the validation studies done in adults in Western Kenya [
12]. We are therefore reasonably confident that our estimates of depression in this study are valid. The adapted HEADSS tool enabled the identification of 12 adolescents with suicidal ideation. This was 4% of the study population and was the first time this diagnosis was made in these adolescents. This finding alone is a strong justification for routine use of HEADSS tool in assessing HIV-infected adolescents.
There is a need to delve further and make a DSM-V diagnosis of depression as part of the strategy to develop more refined criteria for diagnosis of major depression among ALHIV. This study contributes to the growing body of studies using standardized tools. There is a need for validation of this abbreviated tool against the comprehensive HEADSS and other measures of depression such as Beck Depression Inventory version II (BDI-II) and The Children’s Depression Rating Scale-Revised (CDRS-R).
A major limitation of the study was its cross-sectional design, meaning that exposure and outcome were measured at the same time, and therefore causal relationships could not be ascertained. Further to this, the study did not use the full-length HEADSS tool and therefore there is a need for further work to adapt the tool to our environment. Many of the questions posed in this tool are sensitive and there may have been some bias if adolescents engaged in face-to-face interviews under reporting or gave socially acceptable responses. Despite these limitations, the interviews tapped into important areas which need to be investigated in further details. The study did not have a comparison group of adolescents with a different chronic illness and therefore cannot establish whether the depression symptoms are unique to HIV-infected adolescents or a feature of adolescents struggling with chronic illness.
Authors’ contributions
DG, RN, DW, and MK designed the study. Data collection was carried out by DG, NW, and MK. Data analysis and writing of the paper was done by DG, RN, MK, and DW. All authors read and approved the final manuscript.